当前位置: 花猫加速器 > 资讯 > 其他
如何注册ins_怎样有自己的ins
公众号:怎样关注ins 作者:萧发茂 2023-03-03 08:18作者 | 萧发茂
来源 | 花猫加速器(ID:EC-MKT)
WU-KONG6作为首个针对携带EGFRexon20in的晚期非小细胞肺癌(NSCLC)患者的注册研究,在中国注册EGFRexon20inNSCLC与suvotinib达到了主要终点,临床结果令人鼓舞。 WU-KONG6是一项在中国进行的开放标签、单臂、多中心的II期注册研究,其主要终点是客观反应率(ORR),由盲法独立中央审查委员会(BICR)确认。 达到了研究的主要终点,疗效极佳...
Web3风靡娱乐圈:StephenChowins发了工作offer,周杰伦在NFTStephenChow的推特上,再次将Web3带到了公众视野。 "在黑暗中寻找优秀的Web3人才。人才要求:熟悉Web3;有项目管理经验;聪明且心地善良。招聘范围:帮助我打造创意未来。"一向低调的周星驰突然注册开设INS账号,招募高知名度的Web3人才,为自己造势3. Takeaquicklook,asacomedy...
DizheMedicine:Suvotinib-relatedregistrationclinicalstudyreachedtheprimaryendpoint[DizheMedicine:Suvotinib-relatedregistrationclinicalstudyreachedtheprimaryendpoint]"KechuangbanDaily"onthe5th,DizheMedicineannounced,AttheEuropeanSocietyforMedicalOncology(ESMO)Congressin2022,thecompanyannouncedtheresultsofaChineseregistrationclinicaltrialofsuvotinib(DZD9008,sunvozertinib)inthetreatmentofEGFRexon20insertion(Exon20ins)mutantadvancednon-smallcelllungcancer. 独立...
+ω+
DizheMedicine(688192.SH):TheChineseregisteredclinicalstudyofsuvotinibinthetreatmentofcertainlungcancershasreached...ZhitongFinanceAPPNews,DizheMedicine(688192.SH)announcedthatthecompanywillbeinthe2022EuropeanOncologyTheSocietyofInternalMedicine(ESMO)CongressannouncedtheresultsoftheChineseregistrationclinicaltrialofsuvotinib(DZD9008,sunvozertinib)inthetreatmentofEGFRexon20insertion(Exon20ins)mutantadvancednon-smallcelllungcancer,whichwasapprovedbytheblindedindependentcenterevaluationcommittee(BICR). )评估确认的肿瘤反应(O...
DizheMedicine's"Suvotinib"treatsadvancedNSCLCwithEGFRexon20insertionmutation...OnSeptember5,DizheMedicinedisclosedthatitannouncedSuvotinibattheEuropeanSocietyforMedicalOncology(ESMO)Congressin2022TheresultsoftheChineseregistrationclinicaltrialofDZD9008,sunvozertinibinthetreatmentofadvancednon-smallcelllungcancerwithEGFRexon20insertion(Exon20ins)mutation,thetumorresponserate(ORR)confirmedbytheblindedindependentcenterevaluationcommittee(BICR)59.8%,theregisteredclinical...
——END——
![](yubb_theme/picture/m2.png)
相关文章
- 全部评论(0)
![](yubb_theme/picture/default_head_img.gif)